GemVax&KAEL Co.,Ltd.

A082270

KR7082270000

Semiconductors

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-05-02 pm EDT			5-day change	1st Jan Change
12,110 ^KRW	+0.92%		+8.12%	-8.81%

May. 02	Gemvaxlink Co., Ltd. announced that it has received KRW 39.0999772 billion in funding from GemVax&KAEL Co.,Ltd., Keonyang Co., Ltd., Wingbridge I&D Co., Ltd., Kaffaint Co. Ltd	CI
Mar. 25	GemVax&KAEL Co.,Ltd. announced that it has received KRW 17.6 billion in funding from Kiwoom Asset Management Co., Ltd., J&J Assets Management Ltd., Youngjin Industry Co., Ltd. and other investors	CI

GemVax&KAEL Co.,Ltd authorizes a Buyback Plan.

June 13, 2022

The Board of Directors of GemVax&KAEL Co.,Ltd has authorized a buyback plan on June 14, 2022.

Latest news about GemVax&KAEL Co.,Ltd.

Gemvaxlink Co., Ltd. announced that it has received KRW 39.0999772 billion in funding from GemVax&KAEL Co.,Ltd., Keonyang Co., Ltd., Wingbridge I&D Co., Ltd., Kaffaint Co. Ltd	May. 01	CI
GemVax&KAEL Co.,Ltd. announced that it has received KRW 17.6 billion in funding from Kiwoom Asset Management Co., Ltd., J&J Assets Management Ltd., Youngjin Industry Co., Ltd. and other investors	Mar. 24	CI
GemVax&KAEL Co.,Ltd. announced that it expects to receive KRW 17.6 billion in funding from Kiwoom Asset Management Co., Ltd., J&J Assets Management Ltd., Youngjin Industry Co., Ltd. and other investors	Mar. 20	CI
Gemvaxlink Co., Ltd. announced that it has received KRW 29.099978456 billion in funding from GemVax&KAEL Co.,Ltd., Keonyang Co., Ltd., Wingbridge I&D Co., Ltd., Kaffaint Co. Ltd and other investors	Mar. 17	CI
Tranche Update on GemVax&KAEL Co.,Ltd's Equity Buyback Plan announced on June 14, 2022.	22-08-31	CI
GemVax&KAEL Co.,Ltd announces an Equity Buyback for 150,000 shares.	22-06-13	CI
GemVax&KAEL Co.,Ltd authorizes a Buyback Plan.	22-06-13	CI
Tranche Update on GemVax&KAEL Co.,Ltd's Equity Buyback Plan announced on April 13, 2022.	22-06-13	CI
GemVax&KAEL Co.,Ltd's Equity Buyback announced on April 13, 2022, has closed with 300,000 shares, representing 0.76% for KRW 4,333.75 million.	22-06-09	CI
GemVax&KAEL Co.,Ltd announces an Equity Buyback for 300,000 shares.	22-04-13	CI
GemVax&KAEL Co.,Ltd authorizes a Buyback Plan.	22-04-12	CI
GemVax&KAEL Co.,Ltd(KOSDAQ:A082270) added to S&P Global BMI Index	21-09-20	CI
GemVax&KAEL Co.,Ltd acquired additional 12.9% stake in Gemvaxlink Co., Ltd. for KRW 18 billion.	21-08-18	CI
GemVax&KAEL Co.,Ltd acquired additional 12.99% stake in Gemvaxzio Co., Ltd. for KRW 18.02 billion.	21-08-18	CI
GemVax's Highly Promising Phase II Alzheimer's Disease Clinical Trial Results Targeting Telomerase Published in Alzheimer's Research & Therapy' Journal	21-03-30	CI
GemVax&KAEL Co.,Ltd(KOSDAQ:A082270) dropped from S&P Global BMI Index	21-03-22	CI
GemVax & KAEL Announces the Decision to Apply for an Expanded Access IND for Its Lead Candidate GV1001 to Include Additional Investigational Groups in Alzheimer's	20-10-06	CI
Gemvaxzio Co., Ltd. announced that it has received KRW 3.49999944 billion in funding from GemVax&KAEL Co.,Ltd	20-06-17	CI
Gemvaxzio Co., Ltd. announced that it expects to receive KRW 3.49999944 billion in funding from GemVax&KAEL Co.,Ltd	20-06-09	CI
Gemvaxzio Co., Ltd. announced that it has received KRW 4.999999927 billion in funding from GemVax&KAEL Co.,Ltd	20-04-15	CI
Gemvaxzio Co., Ltd. announced that it expects to receive KRW 4.999999927 billion in funding from GemVax&KAEL Co.,Ltd	20-04-07	CI
Gemvaxzio Co., Ltd. announced that it has received KRW 8.4 billion in funding from GemVax&KAEL Co.,Ltd	20-03-29	CI
GemVax Announces Phase II Results of GV1001 for Alzheimer's Disease Treatment at CTAD 2019	19-12-11	CI
Enerzent Co., Ltd. announced that it has received KRW 10 billion in funding from GemVax&KAEL Co.,Ltd	19-02-10	CI
GemVax&KAEL Co.,Ltd announced that it has received KRW 35 billion in funding	18-08-09	CI

GemVax & KAEL Co.,Ltd is a Korea-based company mainly engaged in the manufacture of pollution control equipment used in semiconductor manufacturing processes. The Company and its subsidiaries are engaged in the three categories of businesses: pollution control business, which manufactures chemical air (CA) filters, gas scrubbers, resins, coating resins and other environmental equipments and systems; anticancer and anti-inflammation business, which engages in development of cancer vaccines for infectious diseases, such as acquired immune deficiency syndrome (AIDS) and anti-inflammations, and IT business which mainly produces liquid crystal display (LCD) modules. The Company distributes its products within domestic market and to overseas markets.

Sector

Semiconductors

Calendar

2024-05-12 - Q1 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Semiconductors

	1st Jan change	Capi.
GEMVAX&KAEL CO.,LTD.	-8.81%	352M
NVIDIA CORPORATION	+79.29%	2,185B
TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY LIMITED	+31.53%	627B
BROADCOM INC.	+14.50%	592B
AMD (ADVANCED MICRO DEVICES)	+2.16%	243B
QUALCOMM, INC.	+24.21%	200B
TEXAS INSTRUMENTS INCORPORATED	+4.96%	163B
INTEL CORPORATION	-38.51%	132B
MICRON TECHNOLOGY, INC.	+34.40%	127B
ARM HOLDINGS PLC	+35.34%	105B